Recent Posts
- Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions
- KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure
- KidneyCell Announces Issuance U.S. Patent No. 10,646,644 May 12th, 2020 with 20 Years Patent Life for Bioelectric and Biologics Based Kidney Regeneration
- KidneyCell Files Patent for Precise Bioelectric Klotho Increase Up to 430%
- Leonhardt’s Launchpads Medtech Accelerator Expands into Pittsburgh